Viewing data from:

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

ANDA

GLIPIZIDE; METFORMIN HYDROCHLORIDE | A077270 | TEVA PHARMACEUTICALS USA

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 3 NDCs

Highest NADAC/Unit

$0.2803

per ea

Lowest NADAC/Unit

$0.1981

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00093745501GLIPIZIDE-METFORMIN 2.5-250 MG	$0.2803	EA	Generic	—	2026-08-19
00093745601GLIPIZIDE-METFORMIN 2.5-500 MG	$0.2478	EA	Generic	—	2026-08-19
00093745701GLIPIZIDE-METFORMIN 5-500 MG	$0.1981	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$66.66

Highest Price

$71.23

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
42291-0305-01METAGLIP 2.5MG/500MG TAB	$66.66	FSS	AvKare, LLC	06/14/2028
42291-0306-01GLIPIZIDE 5MG/METFORMIN HCL 500MG TAB	$71.23	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Nov 1, 2005	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 2.5MG;250MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Oct 28, 2005

No patent or exclusivity listings for this strength.

#002 — 2.5MG;500MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 28, 2005

#003 — 5MG;500MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Oct 28, 2005